CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Abacavir sulfate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00087945
NCT00087945N/ACompleted
CompareCT.gov

Abacavir Pharmacokinetics During Chronic Therapy in HIV-1 Infected Adolescents and Young Adults

National Institute of Allergy and Infectious Diseases (NIAID)·interventional·Posted Jul 19, 2004·Updated Oct 8, 2013

In Brief

A clinical study evaluating Abacavir sulfate and Abacavir sulfate, lamivudine, and zidovudine for HIV Infections. Completed, across 20 sites in 2 countries.

Detailed Summary

The way abacavir (ABC) behaves in the body differs between children and adults, but little is known about ABC in adolescents. It is unclear if adult doses of ABC are appropriate for adolescents. The purpose of this study is to determine the blood levels of ABC in HIV infected adolescents who are on ABC-containing regimens.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesPuerto Rico, United States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 19, 2004
Enrollment StartJul 1, 2004
Study CompletionDec 1, 2004
TodayJul 2, 2026
Posted 22.0 years ago

Interventions

Abacavir sulfatedrug

Abacavir sulfate, lamivudine, and zidovudinedrug